Virtus Biotech Clinical Trials ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.79
資產淨值: 43.31
成立日期: 16/12/2014
 
分析
市值分佈:
23.20%
大市值
44.62%
中市值
28.08%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 124  
0%
 
100%
     10大 (14.75%)
代號 名稱 佔比% 持有日期
ERASErasca2.8027/02/2026
ALMSAlumis Inc.1.9127/02/2026
CRVSCorvus Pharmaceuticals1.6127/02/2026
ALLOAllogene Therapeutics1.3627/02/2026
RZLTRezolute1.3127/02/2026
ELVNEnliven Therapeutics1.3027/02/2026
VTYX--1.2627/02/2026
DICE--1.2331/07/2023
ACLXArcellx1.1727/02/2026
NTLAIntellia Therapeutics1.1327/02/2026
RCKTRocket Pharmaceuticals1.0927/02/2026
TYRATyra Biosciences1.0927/02/2026
CGONCG Oncology1.0627/02/2026
ORICOric Pharmaceuticals1.0627/02/2026
DFTXDefinium Therapeutics Inc1.0327/02/2026
PCVXVaxcyte1.0227/02/2026
PVLAPalvella Therapeutics Inc1.0127/02/2026
VIRVir Biotechnology1.0027/02/2026
BLTEBelite Bio0.9927/02/2026
DNTHDianthus Therapeutics0.9727/02/2026
 1    2    3    4    5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.